started · updated
Roche introduces AXELIOS 1 sequencing technology in Asia Pacific
Roche is expanding its next-generation sequencing (NGS) presence in the Asia Pacific region following the global launch of its AXELIOS 1 platform. The technology utilizes proprietary sequencing by expansion (SBX) to provide researchers with increased speed, accuracy, and flexibility across various genomic workflows.
To promote the technology, Roche will host AXELIOS Days in Sydney, Australia, and Seoul, South Korea, this November. These events aim to connect laboratory leaders and researchers to explore the platform's potential for studying complex diseases and regional genetic diversity.
The Asia Pacific NGS market is projected to grow from US$3.4 billion in 2025 to US$7.38 billion by 2030. Roche aims to address the increasing demand for efficient, large-scale genomic studies within the region's growing ecosystems.